DD
Pfizer Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Danuglipron (GLP-1/GIP) | Obesity, Type 2 Diabetes | Phase 3 |
| PF-07081532 (GLP-1R) | Obesity, Type 2 Diabetes | Phase 3 |
| Vepdegestrant (ARV-471) | ER+/HER2- Breast Cancer | Phase 3 |
| Marstacimab | Hemophilia A/B | Phase 3 |
| RSV mRNA Vaccine | Prevention of RSV | Phase 3 |
| Influenza mRNA Vaccine | Seasonal Influenza Prevention | Phase 3 |
| Atidarsagene autotemcel | Metachromatic Leukodystrophy (MLD) | Phase 3 |
| PF-06939926 | Duchenne Muscular Dystrophy | Phase 3 |